Hyderabad-based pharmaceutical manufacturer producing sterile formulations from a single Turkapally facility, operating as a Loan License manufacturer for Sun Pharmaceutical Industries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 61 |
| Reserves | -11 | -13 | 10 | 21 | 30 | 35 | 35 | 34 |
| Borrowings | 21 | 21 | 6 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 15 | 17 | 17 | 19 | 16 | 15 | 15 | 16 |
| Total Liabilities | 86 | 86 | 94 | 101 | 106 | 111 | 111 | 111 |
| AssetsFixed Assets | 49 | 74 | 71 | 65 | 66 | 61 | 60 | 62 |
| CWIP | 29 | 2 | 0 | 5 | 2 | 4 | 5 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 9 | 23 | 31 | 39 | 47 | 46 | 45 |
| Total Assets | 86 | 86 | 94 | 101 | 106 | 111 | 111 | 111 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -14 | 11 | 6 | 18 | 21 | 12 | 9 | 10 |
| Cash from Investing | -16 | -21 | -5 | -2 | -6 | -21 | 15 | -6 |
| Cash from Financing | 15 | -3 | 0 | -16 | -6 | 0 | 0 | 0 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -32 | -10 | 1 | 16 | 14 | 8 | 6 | 2 |
| FCF Margin | — | — | — | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
532039 · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.